Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

1721. Caregiver support for postpartum depression.

Caregiver support for postpartum depression. BACKGROUND: Supportive relationships during the perinatal period may enhance a mother's feeling of wellbeing and control. Support to women during labour and after birth has shown benefits and this may also be the case for mothers with postpartum depression. OBJECTIVES: The objective of this review was to assess the effect of professional and/or social support interventions for the treatment of postpartum depression. SEARCH STRATEGY: We searched (...) the Cochrane Pregnancy and Childbirth Group trials register. Date of last search: January 2001. SELECTION CRITERIA: Randomised and quasi-randomised trials comparing additional support from caregivers with usual forms of care in the postpartum period, in women who were clinically depressed in the six months after giving birth. DATA COLLECTION AND ANALYSIS: Trial quality was assessed and data were extracted by both reviewers. Study authors were contacted for additional information. MAIN RESULTS: Two studies

Cochrane2001

1722. Tryptophan and 5-hydroxytryptophan for depression.

Tryptophan and 5-hydroxytryptophan for depression. BACKGROUND: 5 Hydroxytryptophan (5-HTP) and tryptophan are so-called natural alternatives to traditional antidepressants, used to treat unipolar depression and dysthymia. OBJECTIVES: To determine whether 5-HTP and tryptophan are more effective than placebo, and whether they are safe to use to treat depressive disorders in adults. SEARCH STRATEGY: Trials were searched in computerized general (Medline, Psychlit, and Embase) and specialized (...) databases (Cochrane Controlled Clinical Trials Register, Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trial Register); by checking reference lists of relevant articles; by handsearching relevant specialist journals; and by contacting relevant authors where appropriate. Publications in all languages were sought. SELECTION CRITERIA: Trials were included if they were randomized, included patients with unipolar depression or dysthymia, compared preparations of 5-HTP or tryptophan

Cochrane2001

1723. Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials

Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials Maneeton N, Srisurapanont M Authors' objectives To determine the efficacy and acceptability of tricyclic (...) antidepressants (TCAs) in the treatment of depressive disorders in children and adolescents. Searching MEDLINE was searched from 1966 to October 1999, and the Cochrane Controlled Trials Register from 1980 to October 1999, using the following search strategy: ('antidepressive-agent', 'amitriptyline', 'amoxapine', 'clomipramine', 'desipramine', 'doxepine', 'imipramine', 'maprotiline', 'mianserine', 'nortriptyline', 'protriptyline' or 'trimipramine') and ('child*' or 'adolescent*') and ('depressive disorder

DARE.2000

1724. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm

Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm Nolen W A, Bloemkolk D Authors' objectives To discuss all controlled studies on the treatment of bipolar depression with mood stabilisers or antidepressants, with an emphasis on both their acute effect against (...) depression as well as their risk to induce mania or hypomania. Searching MEDLINE was searched from 1960 to 1999 (updated to February 2000) for literature; the search terms were reported. In addition, reference lists were examined and recent books of congress abstracts were searched. Study selection Study designs of evaluations included in the review Double-blind randomised controlled trials (RCTs), with or without a placebo group, were eligible. Specific interventions included in the review Studies

DARE.2000

1725. Efficacy of newer medications for treating depression in primary care patients

Efficacy of newer medications for treating depression in primary care patients Efficacy of newer medications for treating depression in primary care patients Efficacy of newer medications for treating depression in primary care patients Mulrow C D, Williams J W, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, Cornell J, Stamm K Authors' objectives To review the literature to summarise the efficacy of recently introduced medications in the treatment of depression in adult patients (...) in the primary care setting. Searching English and non-English literature sources were identified using the Cochrane Collaboration Depression Anxiety and Neurosis group's specialised registry of 8451 clinical trial articles (1980 to January 1998). The search terms used were 'depression', 'depressive disorder', or 'dysthymic disorder' and these were combined with the names of the 32 medications to be covered by the review. References from clinical trial and meta-analyses articles were checked and experts were

DARE.2000

1726. Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials

Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials Citalopram therapy for depression: a review of 10 years of European experience and data from US clinical trials Keller M B Authors' objectives To review a decade of experience with citalopram, focusing mainly on efficacy, safety, and tolerability data derived from randomised (...) , well-controlled clinical trials of patients with depression. Searching MEDLINE was searched from 1966 to 2000 to identify relevant English language publications, using the following terms: 'citalopram', 'SSRI', 'TCA', 'depression' and 'clinical'. Published biographies were cross-referenced to locate additional primary sources of information. Data presented at major medical conferences and published in abstract form were also reviewed. Study selection Study designs of evaluations included

DARE.2000

1727. St John's Wort for depression: a systematic review

St John's Wort for depression: a systematic review St John's Wort for depression: a systematic review St John's Wort for depression: a systematic review Gaster B, Holroyd J Authors' objectives To address whether St John's Wort is useful for the treatment of depression. Searching MEDLINE, EMBASE, PsychINFO, and the Cochrane Library databases were searched for articles published between January 1980 and September 1998, using the following search terms: wort and hyperic*. In addition, manual (...) searches of reference lists were conducted. Trade journals, manufacturers and retail sellers, and experts in the fields of depression and herbal medicine were contacted to try and identify any further studies. Only English language articles were selected. Study selection Study designs of evaluations included in the review Only RCTs that were double-blind were included in the review. Specific interventions included in the review Hypericum extract alone: 900 mg 0.3% hypericin per day (in three divided

DARE.2000

1728. Cost-effectiveness of mirtazapine relative to fluoxetine in the treatment of moderate and severe depression in France

Cost-effectiveness of mirtazapine relative to fluoxetine in the treatment of moderate and severe depression in France Cost-effectiveness of mirtazapine relative to fluoxetine in the treatment of moderate and severe depression in France Cost-effectiveness of mirtazapine relative to fluoxetine in the treatment of moderate and severe depression in France Brown M C, van Loon J M, Guest J F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The new antidepressant drug mirtazapine was compared with fluoxetine. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients with moderate (17-Hamilton-Depression, HAM-D, score of 20 to 25) or severe

NHS Economic Evaluation Database.2000

1729. Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK

Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Borghi J, Guest J F Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients in the UK

NHS Economic Evaluation Database.2000

1730. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients (...) with depression. II: cost effectiveness Bower P, Byford S, Sibbald B, Ward E, King M, Lloyd M, Gabbay M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Non-directive counselling and cognitive-behaviour therapy for patients with depression

NHS Economic Evaluation Database.2000

1731. The London Depression Intervention Trial: randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner - clinical outcome and costs

The London Depression Intervention Trial: randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner - clinical outcome and costs The London Depression Intervention Trial: randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner - clinical outcome and costs The London Depression Intervention Trial: randomised controlled (...) trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner - clinical outcome and costs Leff J, Vearnals S, Brewin C R, Wolff G, Alexander B, Asen E, Dayson D, Jones E, Chisholm D, Everitt B Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment

NHS Economic Evaluation Database.2000

1732. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial

Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial Sacristan J A, Gilaberte I, Boto B, Buesching D P, Obenchain (...) R L, Demitrack M, Sola V P, Alvarez E, Artigas F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Fluoxetine plus pindolol for patients with depressive disorder. Type of intervention Treatment. Economic study type Cost

NHS Economic Evaluation Database.2000

1733. Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom

Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom Pharmacoeconomic analysis of antidepressants for major depressive disorder in the United Kingdom Freeman H, Arikian S, Lenox-Smith A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Antidepressants for major depressive disorder (MDD). The serotonin (5-hydroxytryptamine; 5-HT) and noradrenaline (norepinephrine) reuptake inhibitor (SNRI) venlafaxine was compared with selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population

NHS Economic Evaluation Database.2000

1734. Randomised trial of monitoring, feedback and management of care by telephone to improve treatment of depression in primary care

Randomised trial of monitoring, feedback and management of care by telephone to improve treatment of depression in primary care Randomised trial of monitoring, feedback and management of care by telephone to improve treatment of depression in primary care Randomised trial of monitoring, feedback and management of care by telephone to improve treatment of depression in primary care Simon G E, VonKorff M, Rutter C, Wagner E Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two programmes aimed at improving the treatment of acute depression in primary care were examined. The first programme was feedback alone, which was based on computerised data on prescriptions and visits. The second was feedback plus care management

NHS Economic Evaluation Database.2000

1735. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression

A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression Simpson S, Corney R, Fitzgerald P, Beecham J Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Simpson S, Corney R, Fitzgerald P, Beecham J. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression. Health Technology Assessment 2000; 4(36): 1-83 Authors' objectives To examine the effectiveness and cost-effectiveness of short-term counselling in general practice for patients

Health Technology Assessment (HTA) Database.2000

1736. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive (...) -behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S. Randomised controlled trial of non-directive

Health Technology Assessment (HTA) Database.2000

1737. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression

A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found

NIHR HTA programme2000

1738. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care Journals Library An error has occurred in processing the XML document An error

NIHR HTA programme2000

1739. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care.

Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. 10617523 2000 02 08 2000 02 08 2014 06 15 0959-8138 320 7226 2000 Jan 01 BMJ (Clinical research ed.) BMJ Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. 26-30 To determine whether problem solving treatment combined with antidepressant medication is more (...) effective than either treatment alone in the management of major depression in primary care. To assess the effectiveness of problem solving treatment when given by practice nurses compared with general practitioners when both have been trained in the technique. Randomised controlled trial with four treatment groups. Primary care in Oxfordshire. Patients aged 18-65 years with major depression on the research diagnostic criteria-a score of 13 or more on the 17 item Hamilton rating scale for depression

BMJ2000 Full Text: Link to full Text with Trip Pro

1740. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.

Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. 10634337 2000 01 28 2000 01 28 2016 10 17 0098-7484 283 2 2000 Jan 12 JAMA JAMA Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. 212-20 Care of patients with depression in managed primary care settings often fails to meet guideline standards, but the long-term impact of quality improvement (QI (...) ) programs for depression care in such settings is unknown. To determine if QI programs in managed care practices for depressed primary care patients improve quality of care, health outcomes, and employment. Randomized controlled trial initiated from June 1996 to March 1997. Forty-six primary care clinics in 6 US managed care organizations. Of 27332 consecutively screened patients, 1356 with current depressive symptoms and either 12-month, lifetime, or no depressive disorder were enrolled. Matched

JAMA2000